The molecular signature of oncofusion proteins in acute myeloid leukemia

被引:76
作者
Martens, Joost H. A. [1 ]
Stunnenberg, Henk G. [1 ]
机构
[1] Radboud Univ Nijmegen, Dept Mol Biol, Fac Sci, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands
关键词
Acute myeloid leukemia; Oncofusion protein; Transcriptional regulation; Epigenetic; ACUTE PROMYELOCYTIC LEUKEMIA; SERUM RESPONSE FACTOR; ACUTE LYMPHOBLASTIC-LEUKEMIA; MYOSIN HEAVY-CHAIN; GENE-EXPRESSION; FUSION PROTEIN; TRANSCRIPTION FACTOR; RAR-ALPHA; HISTONE DEACETYLASE; HEMATOPOIETIC-CELLS;
D O I
10.1016/j.febslet.2010.04.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Acute myeloid leukemia (AML) associated translocations often cause gene fusions that encode onco-fusion proteins. Although many of the breakpoints involved in chromosomal translocations have been cloned, in most cases the role of the chimeric proteins in tumorigenesis is not elucidated. Here we will discuss the fusion proteins of the 4 most common translocations associated with AML as well as the common molecular mechanisms that these four and other fusion proteins utilize to transform progenitor cells. Intriguingly, although the individual partners within the fusion proteins represent a wide variety of cellular functions, at the molecular level many commodities can be found. (C) 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:2662 / 2669
页数:8
相关论文
共 73 条
[1]   Acute myeloid leukemia fusion proteins deregulate genes involved in stem cell maintenance and DNA repair [J].
Alcalay, M ;
Meani, N ;
Gelmetti, V ;
Fantozzi, A ;
Fagioli, M ;
Orleth, A ;
Riganelli, D ;
Sebastiani, C ;
Cappelli, E ;
Casciari, C ;
Sciurpi, MT ;
Mariano, AR ;
Minardi, SP ;
Luzi, L ;
Muller, H ;
Di Fiore, PP ;
Frosina, G ;
Pelicci, PG .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (11) :1751-1761
[2]   Hox genes in hematopoiesis and leukemogenesis [J].
Argiropoulos, B. ;
Humphries, R. K. .
ONCOGENE, 2007, 26 (47) :6766-6776
[3]   MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia [J].
Armstrong, SA ;
Staunton, JE ;
Silverman, LB ;
Pieters, R ;
de Boer, ML ;
Minden, MD ;
Sallan, SE ;
Lander, ES ;
Golub, TR ;
Korsmeyer, SJ .
NATURE GENETICS, 2002, 30 (01) :41-47
[4]   Binding to nonmethylated CpG DNA is essential for target recognition, transactivation, and myeloid transformation by an MLL oncoprotein [J].
Ayton, PM ;
Chen, EH ;
Cleary, ML .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (23) :10470-10478
[5]   The MN1-TEL fusion protein, encoded by the translocation (12;22)(p13;q11) in myeloid leukemia, is a transcription factor with transforming activity [J].
Buijs, A ;
van Rompaey, L ;
Molijn, AC ;
Davis, JN ;
Vertegaal, ACO ;
Potter, MD ;
Adams, C ;
van Baal, S ;
Zwarthoff, EC ;
Roussel, MF ;
Grosveld, GC .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (24) :9281-9293
[6]   The role of EVI1 in normal and leukemic cells [J].
Buonamici, S ;
Chakraborty, S ;
Senyuk, V ;
Nucifora, G .
BLOOD CELLS MOLECULES AND DISEASES, 2003, 31 (02) :206-212
[7]   The Runx genes:: lineage-specific oncogenes and tumor suppressors [J].
Cameron, ER ;
Neil, JC .
ONCOGENE, 2004, 23 (24) :4308-4314
[8]   Megakaryoblastic leukemia 1, a potent transcriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes [J].
Cen, B ;
Selvaraj, A ;
Burgess, RC ;
Hitzler, JK ;
Ma, ZG ;
Morris, SW ;
Prywes, R .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (18) :6597-6608
[9]   The ETO (MTG8) gene family [J].
Davis, JN ;
McGhee, L ;
Meyers, S .
GENE, 2003, 303 :1-10
[10]   Core-binding factors in hematopoiesis and immune function [J].
de Bruijn, MFTR ;
Speck, NA .
ONCOGENE, 2004, 23 (24) :4238-4248